SCHEMBL6073099

SCHEMBL6073099

O=C(NC1C2CN(CCc3ccc4c(c3)OCO4)CC21)N1CCc2ccccc2C1c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.43
ALDH1A1 P00352 4/20 0.42
SIGMAR1 Q99720 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 3/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
CHRM3 P20309 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
HHAT Q5VTY9 2/20 0.41
CYP2D6 P10635 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6072959 0.80 CHRM3 (0.50) SIGMAR1CHRM3HHATCYP2D6
SCHEMBL30794420 0.75 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL3237239 0.75 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL6073004 0.72 CHRM3 (0.52) CHRM3HHATCYP2D6
SCHEMBL4080455 0.71 CHRM3 (0.47) CHRM3
SCHEMBL8499570 0.70 ALDH1A1 (0.59) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL5948391 0.70 CHRM3 (0.50) CHRM3
SCHEMBL4648949 0.69 PTPN1 (0.45) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL17117236 0.68 HHAT (0.54) HHATCYP2D6
SCHEMBL6072947 0.68 HHAT (0.47) SIGMAR1CHRM3HHATCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006035280-A1 3,4-DIHYDROISOQUINOLINE COMPOUNDS AS MUSCRINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY, URINARY AND GASTROINTESTINAL DISEASES RANBAXY LABORATORIES LIMITED (IN) 2006-04-06 WO claimed
WO-2006035280-A1 3,4-DIHYDROISOQUINOLINE COMPOUNDS AS MUSCRINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY, URINARY AND GASTROINTESTINAL DISEASES RANBAXY LABORATORIES LIMITED (IN) 2006-04-06 WO disclosed